Fujishima H, Mitsugi K, Nakamura M, Yoshimatsu H, Nakano S, Niho Y
First Dept. of Internal Medicine, Faculty of Medicine, Kyushu University.
Gan To Kagaku Ryoho. 1994 May;21(6):869-72.
A 65-year-old man complaining of nausea and loss of appetite was diagnosed as having Borrmann type 3 gastric cancer with multiple liver metastasis. He was treated for 5 days with bolus injections of l-leucovorin (l-LV: 100 mg/m2/day) followed by 5-fluorouracil (5-FU; 370 mg/m2/day), and this was repeated every 4 weeks. The computed tomography scan after 3 cycles showed an approximately 70% decrease in the size of metastatic lesions, indicating a partial response. The primary gastric lesion also showed a partial response. There were modest but tolerable side effects such as diarrhea. After 3 cycles, the patient was discharged and was given oral 5-FU preparation. He died 9 months after initial chemotherapy with a response duration of 5 months. This l-LV and 5-FU combination therapy appears useful for advanced gastric cancer.
一名65岁男性,因恶心和食欲不振就诊,被诊断为Borrmann 3型胃癌伴多发肝转移。他接受了为期5天的推注治疗,先给予左亚叶酸钙(l-LV:100 mg/m²/天),随后给予5-氟尿嘧啶(5-FU;370 mg/m²/天),每4周重复一次。3个周期后计算机断层扫描显示转移灶大小缩小约70%,提示部分缓解。胃原发性病变也显示部分缓解。有一些适度但可耐受的副作用,如腹泻。3个周期后,患者出院并给予口服5-FU制剂。他在初始化疗9个月后死亡,缓解持续时间为5个月。这种l-LV与5-FU联合疗法似乎对晚期胃癌有效。